Compared with the non-NAFLD group, levels of ACAG, ALT, AST, BUN, glucose, and triglyceride were significantly elevated in the NAFLD group, and exhibited an increased trend across NAFLD without CSF and NAFLD with CSF (P < 0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.